Clinical Lab Focus Leverage ASHI and CLIA certifications to target clinical laboratories and transplant programs requiring high-precision immune gene typing. Scisco Genetics offers HLA typing and KIR haplotyping via Scisco Services and ScisGo Kits on an Illumina MiSeq platform, positioning for regulated clinical deployments and revenue opportunities in transplant support and immunogenetics.

End-to-End NGS Offer a turnkey NGS solution stack combining Scisco Services for immune genotyping, ScisGo Kits for phased HLA typing, and ScisCloud Software for laboratory workflow and data management. This end-to-end capability enables sales teams to upsell to labs seeking integrated testing, workflow automation, and data stewardship within a single vendor.

Regulatory Advantage Distinct regulatory credentials and a focus on precision set Scisco Genetics apart in a competitive market. Emphasize quality assurance and regulatory compliance to win contracts with hospitals, reference labs, and clinical labs that must meet stringent standards for immune-typing services.

Market Expansion Target expansion opportunities beyond Seattle by engaging transplant centers, academic research institutions, and biotech partners in immunogenetics. The company's scalable services and cloud-based data management support collaborations for large studies and clinical implementations, broadening the addressable market.

Data Solutions Capitalize on the ScisCloud and cloud-ready data approach to sell data management, analytics, and secure storage as an add-on. With platforms leveraging cloud storage and modern workflow software, there is a clear upsell path for labs looking to improve data traceability, reproducibility, and regulatory reporting.